| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/14/2001 | EP0973563A4 System, method and composition for dialysis and shock treatment |
| 03/14/2001 | EP0973533A4 Methods for inhibiting bacterial cytotoxicity |
| 03/14/2001 | EP0960128A4 Gene product over expressed in cancer cells |
| 03/14/2001 | EP0812205B1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 03/14/2001 | EP0808203B1 Centrifuge with annular filter |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0804478B1 Growth factor analogs |
| 03/14/2001 | EP0675730B1 Therapeutic combination containing interferon |
| 03/14/2001 | EP0671472B1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 03/14/2001 | EP0640143B1 Senescent cell derived inhibitors of dna synthesis |
| 03/14/2001 | EP0584279B1 Targeted delivery of genes encoding immunogenic proteins |
| 03/14/2001 | CN1287492A Method for administering ASPB 28-human insulin |
| 03/14/2001 | CN1287491A Method for administering monomeric insulin analogs |
| 03/14/2001 | CN1287199A Enzymatic wet paper napkin and its production process |
| 03/14/2001 | CN1287174A Recombined new thrombolytic enzyme |
| 03/14/2001 | CN1287124A Recombined natural and new-type human insulin and its preparation |
| 03/14/2001 | CN1287009A Sucked insulin preparation |
| 03/14/2001 | CN1287008A Achyranthis bidentatae glycopeptide and its preparation |
| 03/14/2001 | CN1063185C Heri factor coupled material, its producing method, composition containing it and application thereof |
| 03/14/2001 | CN1063090C Injection for varicose vein |
| 03/14/2001 | CN1063055C Medicine for curing bee disease |
| 03/14/2001 | CA2300328A1 Modulating transcription of genes in vascular cells |
| 03/13/2001 | US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control |
| 03/13/2001 | US6201115 Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications |
| 03/13/2001 | US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors |
| 03/13/2001 | US6201110 Mixture of protease conjugated to polymer with molecular weight from 1 to 60 kilodaltons and another substance which makes it unsuitable for pharmaceutical use; cosmetics; dentrifices; detergents; hair spray; shampoo; agrochemicals |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201106 Cytokine signal regulators |
| 03/13/2001 | US6201105 Amino acid sequence; treatment of septic shock and cachexia; diagnosis |
| 03/13/2001 | US6201104 Amino acid sequences of angiogenesis-inhibiting protein receptor; drug screening; isolation of angiogenesis related proteins |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6201072 Block copolymers of polyether and polyester |
| 03/13/2001 | US6201065 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 03/13/2001 | US6200969 Contacting cells with reagent which suppresses protease activity of interleukin-1.beta.-converting enzyme (ice)/ced-3 family, inhibiting apoptosis in cell population to expanding or increasing survival of cell population |
| 03/13/2001 | US6200967 Used as thrombin inhibitors, coagulation inhibitors and agents for the treatment of thromboembolic disorders |
| 03/13/2001 | US6200960 Inhibition of proliferation of cells |
| 03/13/2001 | US6200957 Useful for treatment of variety of sex-hormone related and other conditions in both men and women |
| 03/13/2001 | US6200956 Nucleic acid-containing composition, preparation and use thereof |
| 03/13/2001 | US6200955 Heparin binding peptides |
| 03/13/2001 | US6200954 Small peptides having potent anti-angiogenic activity |
| 03/13/2001 | US6200953 Relaxin analogs and derivatives compositions |
| 03/13/2001 | US6200952 Combination therapy method for treating chronic hepatitis B |
| 03/13/2001 | US6200951 For detecting chitin, binding chitin, and treating fungal infections or for development of products useful for fungal infection therapy |
| 03/13/2001 | US6200950 Nutritional suppliment |
| 03/13/2001 | US6200811 For making human immunodeficiency virus resistant cells; gene therapy |
| 03/13/2001 | US6200810 Administering a synthetic mutated retinoblastoma gene encoding a protein resistant to deactivation by phosphorylation; antiproliferative/anticancer agents |
| 03/13/2001 | US6200807 Antisense inhibition of SHP-2 expression |
| 03/13/2001 | US6200803 Preventing fungal contamination in cell culture by incubating cells in cell culture medium with either antisense oligonucleotide or ribozyme complementary to messenger rna of essential yeast genes |
| 03/13/2001 | US6200800 Defective moloney murine leukemia provirus used as retroviral vector for gene therapy and vaccines; has recognition sequence for elimination of proviral sequences for more accurate and safe use |
| 03/13/2001 | US6200798 Defective recombinant adenoviruses with inactivated IVa2 gene |
| 03/13/2001 | US6200796 Nucleotide and amino acid sequences; recombinant production; treatment of urolithiasis and hyperoxaluria |
| 03/13/2001 | US6200791 Isolating reptile proteolytic enzyme; obtain solution with proteolytic enzyme, pour solution on matrix, elute proteolytic enzyme, pour on matrix of beads, elute proteolytic enzymes and pour on size exclusion matrix, elute proteolytic enzyme |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200780 Human interferon-ε(IFN-ε), a type I interferon |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200771 Determination cyclooxygenase inhibition and phosphodiesteraseinhibition; calibration |
| 03/13/2001 | US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator |
| 03/13/2001 | US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein |
| 03/13/2001 | US6200758 Detecting a psychological disorders; obtain biopsies, detect nucleotide sequence variation, presence of variation indicates psychological disorders |
| 03/13/2001 | US6200751 Cell preferential regulatory sequences; for the control of transcription from heterologous nucleotide sequences; for use in gene therapy |
| 03/13/2001 | US6200749 Ajusted nucleic acid sequence; for detection of genome adjustments and preferential genetic disorders |
| 03/13/2001 | US6200606 Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| 03/13/2001 | US6200578 Genetic engineered polypeptide |
| 03/13/2001 | US6200577 Anti-herpesviral agents and assays therefor |
| 03/13/2001 | US6200575 These new ?inactivated? immunogens can be used to induce active immunization in humans which is capable of preventing or correcting the deregulatory effects which the native proteins from which they are produced may help to produce. |
| 03/13/2001 | US6200569 Water extract or a dilute acidic extract of polygonum multiform roots or cinnamomum bark; decreasing the glycosylated hemoglobin level or blood glucose level in a hyperglycemic patient |
| 03/13/2001 | US6200567 An antibody that binds to the common beta c chain of the receptor for gm-csf, il-3 and il-5 |
| 03/13/2001 | US6200566 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 03/13/2001 | US6200564 Pharmaceutical compositions containing chondroitinase and uses therefor |
| 03/13/2001 | US6200563 Synthetic mammalian sulphamidase and genetic sequences encoding same |
| 03/13/2001 | US6200562 Method for reducing absorption of dietary oxalate using enzymes and microbes |
| 03/13/2001 | US6200561 Use of viral proteins for controlling the cotton boll weevil and other insect pests |
| 03/13/2001 | US6200560 Adeno-associated virus vectors for expression of factor VIII by target cells |
| 03/13/2001 | US6200546 Gastrin receptor-avid peptide conjugates |
| 03/13/2001 | US6199554 Method and apparatus for combining injury-mediated therapy and drug delivery |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 03/13/2001 | CA2125673C Dna structure-specific recognition protein and uses therefor |
| 03/13/2001 | CA1341204C Analogues of igf-1 and igf-2 |
| 03/08/2001 | WO2001016603A2 Analysis and treatment of body weight and eating disorders |
| 03/08/2001 | WO2001016596A2 Screening for modulators of gaba b receptor activity |
| 03/08/2001 | WO2001016379A1 Hepatitis c virus replication inhibitors |
| 03/08/2001 | WO2001016377A2 Diagnostics and therapeutics for osteoporosis |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016343A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 03/08/2001 | WO2001016334A2 Human hydrolytic enzymes |
| 03/08/2001 | WO2001016326A2 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 03/08/2001 | WO2001016324A2 Methods and compositions of a novel serine protease inhibitor |
| 03/08/2001 | WO2001016323A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016321A1 Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof |
| 03/08/2001 | WO2001016320A1 Isolated nona and decapeptides which bind to hla molecules, and the use thereof |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016317A2 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016314A1 Iren protein, its preparation and use |
| 03/08/2001 | WO2001016312A2 Nucleic acid based modulators of gene expression |